Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide vs Sulfasalazine in Ankylosing Spondylitis
NCT06985134Phase 3Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in ankylosing spondylitis (AS), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jan 2017; status: completed.
02
Drugs
thalidomide
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT06985134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06985134.